Manchester Capital Management LLC Atri Cure, Inc. Transaction History

Manchester Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$40.44 - $49.6 $2,143 - $2,628	-53 Reduced 60.23%	35 $1,000
Q4 2022 Feb 09, 2023	BUY	$33.48 - $47.45 $1,774 - $2,514	53 Added 151.43%	88 $3,000
Q3 2022 Nov 08, 2022	SELL	$38.25 - $52.62 $9,027 - $12,418	-236 Reduced 87.08%	35 $1,000
Q1 2022 May 09, 2022	SELL	$57.43 - $71.39 $13,610 - $16,919	-237 Reduced 46.65%	271 $18,000
Q3 2021 Nov 12, 2021	BUY	$69.28 - $84.46 $32,769 - $39,949	473 Added 1351.43%	508 $35,000
Q2 2021 Aug 16, 2021	BUY	$64.13 - $80.18 $2,244 - $2,806	35 New	35 $3,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.66B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Manchester Capital Management LLC with notifications on news.